Chanfta Bhagat Pharma Ltd (BSE: 542934) is a Mumbai, Maharashtra-based company in the Health Care Distributors industry. With a market capitalisation of ₹0 Cr, it ranks #5,223 by market cap among the 6,197 Indian listed companies on FinBizNet, and #11 of 11 in Health Care Distributors. At ₹60.00 (as of 16 Nov 2026), the share price is 0.1% below its 52-week high of ₹60.06 and 102.0% above its 52-week low of ₹29.70. The share price is up 50.0% over one year and up 14.3% over three months.
| Current Price | ₹60.00 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 542934 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors |
| P/E Ratio | 14.3 |
| Return on Equity | 2.91% |
| Return on Assets | 2.37% |
| 52-Week Range | ₹29.70 – ₹60.06 |
| 1-Year Price Change | +50.0% |
| 3-Month Price Change | +14.3% |
| Beta (1Y) | 0.42 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.cbcpharma.com |
Delivery averaged 100.0% of traded volume across 12 BSE sessions (23 Oct 2026 – 13 Nov 2026).
Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its own brand. The company also promotes and markets specialty chemicals, as well as intermediates and active pharmaceuticals ingredients. It also exports its products. The company was founded in 1944 and is headquartered in Mumbai, India.
1. Pharmaceuticals-This segment offers pharmaceutical formulation and active pharmaceuticals ingredient products.
1. Pharmaceutical Formulations and API Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Trimurthi Ltd | ₹197 Cr | 57.6 | 7.99% | — | +33.3% |
| Achyut Healthcare Ltd | ₹191 Cr | 609.2 | 0.95% | — | +39.7% |
| Vaidya Sane Ayurved Laboratories | ₹148 Cr | — | 13.40% | — | -46.6% |
| Balaxi Pharmaceuticals Ltd | ₹125 Cr | 92.2 | 0.59% | ₹81 Cr | -44.5% |
| Medico Intercontinental Ltd | ₹25 Cr | n/m | -27.14% | ₹14 Cr | -31.5% |
| Zenlabs Ethica Ltd | ₹19 Cr | n/m | -20.44% | — | -12.5% |
| Rubra Medicaments Ltd. | ₹18 Cr | 12.2 | 12.67% | — | -53.2% |
| Nexus Surgical & Medicare Ltd | ₹15 Cr | 20 | 51.41% | — | +76.5% |
| Chanfta Bhagat Pharma Ltd | ₹0 Cr | 14.3 | 2.91% | — | +50.0% |
Listed by market capitalisation. Ratios are shown for context only.
Chanfta Bhagat Pharma Ltd is trading at ₹60.00, with a market capitalisation of ₹0 Cr.
Chanfta Bhagat Pharma Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).
Chanfta Bhagat Pharma Ltd has a P/E of 14.3 and a return on equity of 2.91%.
Chanfta Bhagat Pharma Ltd is listed on the BSE under the scrip code 542934.
Chanfta Bhagat Pharma Ltd's share price is up 50.0% over one year and up 14.3% over three months. Its 52-week range is ₹29.70 to ₹60.06.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.